N or mean ± standard deviation | Percentage or range | |
---|---|---|
Gender | ||
Male | 138 | 80% |
Female | 24 | 14% |
Unspecified | 11 | 6% |
Age at operation (years) | 72.47 ± 7.62 | (52 to 93) |
50 to 59 years | 7 | 4% |
60 to 69 years | 41 | 24% |
70 to 79 years | 83 | 48% |
80 to 89 years | 26 | 15% |
90 to 99 years | 1 | 1% |
Unspecified | 15 | 9% |
Comorbidities | ||
Diabetes | 5 | 3% |
Smoking | 5 | 3% |
Hypertension | 21 | 12% |
Hypercholesterolaemia | 6 | 3% |
Cardiac status | 25 | 14% |
Obesity | 7 | 4% |
Stroke | 5 | 3% |
Pulmonary status | 21 | 12% |
Renal status | 10 | 6% |
Other* | 23 | 13% |
Peripheral vascular disease | 7 | 4% |
Carotid disease | 1 | 1% |
Number of comorbidities | ||
0 or unspecified | 114 | 66% |
1 or 2 | 26 | 15% |
≥3 | 33 | 19% |
AAA diameter | 59.78 ± 11.04 | 42 to 95 |
Incomplete follow-up adherence † | 8 | 5% |
Time interval between EVAR and complication (months) | 13.73 ± 16.11 | 0 to 85 |
Perioperative, up to 24 hours | 31 | 18% |
Initial, up to 30 days post-operative | 28 | 16% |
Short term, 30 days to 6 months | 15 | 9% |
Early mid-term, 6 months to 2 1/2 years | 62 | 36% |
Late mid-term, 2 1/2 years to 5 years | 23 | 13% |
Long term, > 5 years | 4 | 2% |
Unspecified | 10 | 6% |